![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
How SGLT2 Inhibitors Protect The Kidney (Conan Liu, M.D.) View |
![]() |
Dr Julie Lovshin - SGLT2i Cardiorenal mechanisms in diabetes and beyond - summary presentation (At the Limits - Leading Medical Education) View |
![]() |
Cardiorenal protection of SGLT2 drugs (Dr. Mahmoud Elhagaly) View |
![]() |
Are the Cardio Renal Benefits of SGLT2 Inhibitors Due to a Class Effect | Dr. Sachin Chittawar (TheRightDoctors) View |
![]() |
Cardiorenal Risk Reduction in T2DM (Cardiometabolic Health Congress (CMHC)) View |
![]() |
SGLT2 Inhibitors in Chronic Kidney Disease (Harvard Medical School Continuing Education) View |
![]() |
ESC Guidelines: Prescribing SGLT2 inhibitors (English Version) (CardioMinds, Dr. Sherif Altoukhy) View |
![]() |
SGLT2 Inhibition and the Prevention of MACEs (AJMCtv) View |
![]() |
SGLT2 Inhibitors: CV Outcomes Data in Type 2 Diabetes (HCPLive) View |
![]() |
SGLT2 inhibitors and cardiovascular outcomes in type 2 diabetes: VERTIS CV trial (GPnotebook) View |